SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001663577-21-000652
Filing Date
2021-12-03
Accepted
2021-12-03 12:48:24
Documents
20
Period of Report
2021-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 abti8k.htm   iXBRL 8-K 29938
5 ex2_1.htm EX-2.1 51481
6 GRAPHIC image_001.gif GRAPHIC 65
7 GRAPHIC image_007.gif GRAPHIC 74
8 GRAPHIC image_008.gif GRAPHIC 65
9 GRAPHIC image_009.gif GRAPHIC 74
10 GRAPHIC image_005.gif GRAPHIC 65
11 GRAPHIC image_010.gif GRAPHIC 73
12 GRAPHIC image_002.gif GRAPHIC 65
  Complete submission text file 0001663577-21-000652.txt   259397

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abti-20211202.xsd EX-101.SCH 3046
3 XBRL LABEL FILE abti-20211202_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abti-20211202_pre.xml EX-101.PRE 22373
13 EXTRACTED XBRL INSTANCE DOCUMENT abti8k_htm.xml XML 3081
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

IRS No.: 821317032 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-156091 | Film No.: 211469362
SIC: 2833 Medicinal Chemicals & Botanical Products